Invention for Innovation

Vials and syringe

Invention for Innovation (i4i) is a translational funding scheme to advance healthcare technologies and interventions for increased patient benefit in areas of existing or emerging clinical need. Similarly, the Health Innovation Challenge Fund (HIC Fund), a partnership between the Department of Health and the Wellcome Trust, is also a translational funding scheme and complements the NIHR i4i Programme at a key translational gap.

i4i supports collaborative research and development projects that have demonstrated proof-of-principle and have a clear pathway towards adoption and commercialisation. The expected output is an advanced or clinically validated prototype medical device, technology or intervention. The aim is to de-risk projects and make them attractive to follow-on funders and investors.

There are two funding streams, Product Development awards and Challenge awards, which comprise early to late stage product development, including first-in-man and clinical feasibility studies and pivotal clinical studies to evaluate the safety and effectiveness for the intended use. The ultimate aim is to get products or services to a position where they can enter and be used within the NHS.

If you are unsure which i4i funding stream you should submit your application to, please email i4i.programme@nihr-ccf.org.uk, providing a short summary of the proposed research.

The i4i programme has been independently evaluated by RAND Europe. RAND Europe is an independent not-for-profit policy research organisation that aims to improve policy and decision making in the public interest, through research and analysis.

A copy of the full report can be downloaded from this webpage. Alternatively, you can email i4i.programme@nihr-ccf.org.uk to request a copy.

 

 

Apply/manage your award